(Bloomberg) -- A company that has Donald Trump Jr. on its board touted in a press release a new “initiative” to help pharmaceutical companies launch direct sales platforms, one week after President ...
– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral presentation of TransCon PTH Phase 2 PaTH Forward Trial Open-Label ...
Evoke Pharma reported Q1 2025 net product sales of $3.1 million, a 77% increase from the previous year. Despite a significant increase in net product sales, the net loss remains substantial at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback